Pacific Biosciences of California Incのファンダメンタルズは比較的安定です。業界をリードするESG開示とともに。成長の可能性は顕著です。バリュエーションは適正価格と評価されています。医療機器 & 備品業界での順位は205中115位です。機関投資家保有率は非常に高いです。過去1か月間に複数のアナリストがホールドと評価し、最高目標株価は2.21とされています。中期的には、株価は安定推移と予想されます。同社の株式市場でのパフォーマンスは過去1か月間で低調であり、ファンダメンタルズとテクニカルも同様に弱い状態です。株価は支持線と抵抗線の間で横ばい推移しており、レンジ相場でのスイングトレードに適しています。
Pacific Biosciences of California Incのスコア
関連情報
業界内順位
115 / 205
全体ランキング
296 / 4521
業種
医療機器 & 備品
サポートラインとレジスタンスライン
会社から関連データがまだ開示されていません。
レーダーチャート
現在
前回値
メディア報道
過去24時間
報道レベル
非常に低い
非常に高い
ネガティブ
Pacific Biosciences of California Incの注目ポイント
強みリスク
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.